1.
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial
by Bolli, Roberto, Prof
The Lancet (British edition), 2011, Vol.378 (9806), p.1847-1857
2.
CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis
by Zhang, Ting
Nature medicine, 2016-02, Vol.22 (2), p.175-182
3.
Hypoxia-inducible factor 1 and cardiovascular disease
by Semenza, Gregg L
Annual review of physiology, 2014, Vol.76 (1), p.39-56
4.
Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes
by Fang, Ji
Apoptosis (London), 2011-11-27, Vol.17 (4), p.410-423
5.
Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation
by Briceno, Natalia
Heart (British Cardiac Society), 2016-03, Vol.102 (5), p.397-406
6.
Meta-Analysis of Mental Stress–Induced Myocardial Ischemia and Subsequent Cardiac Events in Patients With Coronary Artery Disease
by Wei, Jingkai, BMS
The American journal of cardiology, 2014, Vol.114 (2), p.187-192
7.
Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy
by Prior, John O
European journal of nuclear medicine and molecular imaging, 2005-01, Vol.32 (1), p.60-69
8.
Toll-Like Receptors: New Players in Myocardial Ischemia/Reperfusion Injury
by Ha, Tuanzhu
Antioxidants & redox signaling, 2011-10-01, Vol.15 (7), p.1875-1893
9.
Hype or hope: Vagus nerve stimulation against acute myocardial ischemia-reperfusion injury
by Chen, Mingxian
Trends in cardiovascular medicine, 2020-11, Vol.30 (8), p.481-488
10.
Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (...
by Raungaard, Bent, Dr
The Lancet (British edition), 2015, Vol.385 (9977), p.1527-1535
11.
Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart
by Miller, Edward J
Nature, 2008-01-31, Vol.451 (7178), p.578-582
12.
Melatonin reduces PERK-eIF2α-ATF4-mediated endoplasmic reticulum stress during myocardial ischemia–reperfusion injury: role of RISK and SAFE pathways interaction
by Yu, Liming
Apoptosis (London), 2016-05-11, Vol.21 (7), p.809-824
13.
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial
by Perin, Emerson C., MD, PhD
The American heart journal, 2014, Vol.168 (1), p.88-95.e2
14.
In Older Men an Optimal Plasma Testosterone Is Associated With Reduced All-Cause Mortality and Higher Dihydrotestosterone With Reduced Ischemic Heart Disease Mortality, While Estra...
by Yeap, Bu B
The journal of clinical endocrinology and metabolism, 2014-01, Vol.99 (1), p.E9-E18
15.
Relationship between fine particulate air pollution and ischaemic heart disease morbidity and mortality
by Xie, Wuxiang
Heart (British Cardiac Society), 2015-02, Vol.101 (4), p.257-263
16.
Clinical benefit of high-sensitivity cardiac troponin I in the detection of exercise-induced myocardial ischemia
by Lee, Gino, MD
The American heart journal, 2015, Vol.173, p.8-17
17.
ABSORB II randomized controlled trial. A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold syste...
by Diletti, Roberto
The American heart journal, 2012, Vol.164 (5), p.654-663
18.
LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals
by Haase, Christiane L
The journal of clinical endocrinology and metabolism, 2012-02, Vol.97 (2), p.E248-E256
19.
Electrocardiographic scores of severity and acuteness of myocardial ischemia predict myocardial salvage in patients with anterior ST-segment elevation myocardial infarction
by Fakhri, Yama, MD
Journal of electrocardiology, 2017, Vol.51 (2), p.195-202
20.
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an...
by Serruys, Patrick W, Prof
The Lancet (British edition), 2015, Vol.385 (9962), p.43-54
